Centessa Pharmaceuticals Files Annual Report
Ticker: CNTA · Form: ARS · Filed: Apr 29, 2026 · CIK: 0001847903
| Field | Detail |
|---|---|
| Company | Centessa Pharmaceuticals PLC (CNTA) |
| Form Type | ARS |
| Filed Date | Apr 29, 2026 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: annual-report, sec-filing, pharmaceuticals
TL;DR
Centessa ARS filed for FY25, check it out.
AI Summary
Centessa Pharmaceuticals plc filed an Annual Report to Security Holders (ARS) on April 29, 2026, for the period ending December 31, 2025. The filing, with accession number 0001847903-26-000041, includes a PDF document detailing the company's annual performance. Centessa Pharmaceuticals plc is located at 3RD FLOOR 1 ASHLEY ROAD ALTRINCHAM, CHESHIRE X0 WA14 2DT.
Why It Matters
This filing provides shareholders with an overview of Centessa Pharmaceuticals' financial and operational performance for the fiscal year 2025, which is crucial for investment decisions.
Risk Assessment
Risk Level: low — This is a routine annual report filing and does not contain new material events or financial distress signals.
Key Players & Entities
- Centessa Pharmaceuticals plc (company) — Filer
- 0001847903-26-000041 (filing_id) — SEC Accession Number
- 2026-04-29 (date) — Filing Date
- 2025-12-31 (date) — Period of Report
- 3RD FLOOR 1 ASHLEY ROAD ALTRINCHAM, CHESHIRE X0 WA14 2DT (address) — Mailing and Business Address
FAQ
What type of filing is this?
This is an Annual Report to Security Holders (ARS) filing.
When was this filing submitted?
The filing date was April 29, 2026.
What period does this report cover?
The period of report is for the year ending December 31, 2025.
What is the SEC accession number for this filing?
The SEC accession number is 0001847903-26-000041.
What is the company's business address?
The business address is 3RD FLOOR 1 ASHLEY ROAD ALTRINCHAM, CHESHIRE X0 WA14 2DT.
Filing Details
This Form ARS (Form ARS) was filed with the SEC on April 29, 2026 regarding Centessa Pharmaceuticals plc (CNTA).